Picture of BRAIN Biotech AG logo

BNN BRAIN Biotech AG News Story

0.000.00%
de flag iconLast trade - 00:00
IndustrialsHighly SpeculativeSmall CapMomentum Trap

Brief: BRAIN AG Q1 Adjusted EBITDA Loss Widens To EUR 0.2 Million

Feb 28 (Reuters) - BRAIN Biotechnology Research and
Information Network AG  BNNn.DE :
    * DGAP-NEWS: B.R.A.I.N. BIOTECHNOLOGY RESEARCH AND
INFORMATION
NETWORK AG: BRAIN AG IS STARTING THE 2019/20 FINANCIAL YEAR WITH
A SUCCESSFUL QUARTER
    * DGAP-NEWS: B.R.A.I.N. BIOTECHNOLOGY RESEARCH AND
INFORMATION
NETWORK AG: BRAIN AG IS STARTING THE 2019/20 FINANCIAL YEAR WITH
A SUCCESSFUL QUARTER
    * GROUP EBITDA DECREASED SLIGHTLY FROM EUR -0.1 MILLION TO
EUR
-0.3 MILLION IN FIRST THREE MONTHS OF 2019/20 FINANCIAL YEAR
    * Q1 GROUP REVENUES IN REPORTING PERIOD FROM OCTOBER 1, 2019
TO
DECEMBER 31, 2019 INCREASED BY 9.4% FROM EUR 9.4 MILLION TO EUR
10.3 MILLION.
    * ADJUSTED GROUP EBITDA SHOWED A SLIGHT DECLINE FROM EUR
-0.0
MILLION IN PREVIOUS YEAR TO EUR -0.2 MILLION IN FIRST THREE
MONTHS OF FINANCIAL YEAR 2019/20

Source text for Eikon:  ID:nEQ1TRYyqa 
Further company coverage:  BNNn.DE 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))

Recent news on BRAIN Biotech AG

See all news